UBS Group’s Herbalife HLF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.63M | Buy |
178,352
+29,469
| +20% | +$481K | ﹤0.01% | 4718 |
|
|
2025
Q4 | $1.92M | Sell |
148,883
-509,771
| -77% | -$5.4M | ﹤0.01% | 5015 |
|
|
2025
Q3 | $5.56M | Buy |
658,654
+280,870
| +74% | +$2.65M | ﹤0.01% | 3924 |
|
|
2025
Q2 | $3.26M | Sell |
377,784
-189,110
| -33% | -$1.4M | ﹤0.01% | 4317 |
|
|
2025
Q1 | $4.89M | Buy |
566,894
+80,497
| +17% | +$573K | ﹤0.01% | 3803 |
|
|
2024
Q4 | $3.25M | Sell |
486,397
-4,429,187
| -90% | -$32.9M | ﹤0.01% | 4246 |
|
|
2024
Q3 | $35.3M | Sell |
4,915,584
-265,020
| -5% | -$2.44M | 0.01% | 1403 |
|
|
2024
Q2 | $53.8M | Sell |
5,180,604
-97,343
| -2% | -$973K | 0.01% | 992 |
|
|
2024
Q1 | $53M | Buy |
5,277,947
+1,601,185
| +44% | +$17.2M | 0.01% | 1004 |
|
|
2023
Q4 | $56.1M | Sell |
3,676,762
-312,366
| -8% | -$4.31M | 0.02% | 917 |
|
|
2023
Q3 | $55.8M | Buy |
3,989,128
+218,949
| +6% | +$3.31M | 0.02% | 777 |
|
|
2023
Q2 | $49.9M | Buy |
3,770,179
+532,076
| +16% | +$7.24M | 0.02% | 827 |
|
|
2023
Q1 | $52.1M | Sell |
3,238,103
-292,569
| -8% | -$5.17M | 0.02% | 756 |
|
|
2022
Q4 | $52.5M | Buy |
3,530,672
+1,392,641
| +65% | +$24.3M | 0.02% | 777 |
|
|
2022
Q3 | $42.5M | Buy |
2,138,031
+1,677,226
| +364% | +$41.5M | 0.02% | 774 |
|
|
2022
Q2 | $9.42M | Sell |
460,805
-203,058
| -31% | -$5.02M | ﹤0.01% | 1862 |
|
|
2022
Q1 | $20.2M | Buy |
663,863
+531,268
| +401% | +$20.8M | 0.01% | 1411 |
|
|
2021
Q4 | $5.43M | Buy |
132,595
+129,947
| +4,907% | +$5.41M | ﹤0.01% | 2741 |
|
|
2021
Q3 | $112K | Sell |
2,648
-20,104
| -88% | -$994K | ﹤0.01% | 5757 |
|
|
2021
Q2 | $1.2M | Sell |
22,752
-98,354
| -81% | -$4.89M | ﹤0.01% | 4026 |
|
|
2021
Q1 | $5.37M | Buy |
121,106
+98,350
| +432% | +$4.85M | ﹤0.01% | 2517 |
|
|
2020
Q4 | $1.09M | Sell |
22,756
-5,971
| -21% | -$288K | ﹤0.01% | 3944 |
|
|
2020
Q3 | $1.34M | Sell |
28,727
-37,116
| -56% | -$1.82M | ﹤0.01% | 3425 |
|
|
2020
Q2 | $2.96M | Buy |
65,843
+49,140
| +294% | +$1.91M | ﹤0.01% | 2510 |
|
|
2020
Q1 | $488K | Buy |
16,703
+7,639
| +84% | +$284K | ﹤0.01% | 3977 |
|
|
2019
Q4 | $432K | Buy |
9,064
+4,777
| +111% | +$207K | ﹤0.01% | 4964 |
|
|
2019
Q3 | $162K | Sell |
4,287
-60,900
| -93% | -$2.38M | ﹤0.01% | 5411 |
|
|
2019
Q2 | $2.79M | Sell |
65,187
-195,448
| -75% | -$9.25M | ﹤0.01% | 2848 |
|
|
2019
Q1 | $13.8M | Sell |
260,635
-185,078
| -42% | -$10.6M | 0.01% | 1423 |
|
|
2018
Q4 | $26.3M | Buy |
445,713
+93,300
| +26% | +$5.15M | 0.01% | 905 |
|
|
2018
Q3 | $19.2M | Buy |
352,413
+104,813
| +42% | +$5.79M | 0.01% | 1232 |
|
|
2018
Q2 | $13.3M | Buy |
247,600
+244,194
| +7,170% | +$12.8M | 0.01% | 1489 |
|
|
2018
Q1 | $166K | Sell |
3,406
-1,125,826
| -100% | -$47.8M | ﹤0.01% | 4901 |
|
|
2017
Q4 | $38.2M | Sell |
1,129,232
-3,087,178
| -73% | -$108M | 0.02% | 803 |
|
|
2017
Q3 | $143M | Buy |
4,216,410
+2,226,696
| +112% | +$76.2M | 0.07% | 288 |
|
|
2017
Q2 | $71M | Sell |
1,989,714
-13,652
| -0.7% | -$460K | 0.04% | 445 |
|
|
2017
Q1 | $58.2M | Buy |
2,003,366
+1,995,466
| +25,259% | +$55.5M | 0.03% | 499 |
|
|
2016
Q4 | $190K | Sell |
7,900
-1,113,264
| -99% | -$30.4M | ﹤0.01% | 4825 |
|
|
2016
Q3 | $34.8M | Sell |
1,121,164
-841,942
| -43% | -$26.6M | 0.02% | 665 |
|
|
2016
Q2 | $57.5M | Buy |
1,963,106
+137,608
| +8% | +$4.12M | 0.04% | 445 |
|
|
2016
Q1 | $56.2M | Buy |
1,825,498
+1,535,428
| +529% | +$39.6M | 0.04% | 429 |
|
|
2015
Q4 | $7.78M | Buy |
290,070
+267,976
| +1,213% | +$7.45M | 0.01% | 1600 |
|
|
2015
Q3 | $603K | Sell |
22,094
-99,954
| -82% | -$2.74M | ﹤0.01% | 3736 |
|
|
2015
Q2 | $3.36M | Sell |
122,048
-728,224
| -86% | -$17.6M | ﹤0.01% | 2476 |
|
|
2015
Q1 | $18.2M | Sell |
850,272
-1,103,264
| -56% | -$18.8M | 0.01% | 1030 |
|
|
2014
Q4 | $36.8M | Buy |
+1,953,536
| New | +$41.8M | 0.03% | 673 |
|
Other funds holding HLF
BG
ROIC
VPM
VCM
UBS Group's HLF Position: Q1 2026 in Review
UBS Group increased its Herbalife (HLF) stake by 20% in Q1 2026, buying an estimated $481K and bringing the position to 178,352 shares worth $2.63M. The position accounts for ﹤0.01% of the portfolio, ranked #4718.
UBS Group first reported a position in HLF in Q4 2014 and has held it in 46 quarters since. The position peaked at $143M in Q3 2017. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.
- UBS Group held 178,352 shares of Herbalife worth $2.63M as of Q1 2026.
- UBS Group bought 29,469 Herbalife shares in Q1 2026, an estimated $481K.
- Herbalife made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4718 holding.
- UBS Group first reported a position in Herbalife in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Herbalife position peaked at $143M in Q3 2017.
- 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.